{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T01:32:06Z","timestamp":1769045526495,"version":"3.49.0"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"48","license":[{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,11,28]]},"abstract":"<jats:p>\n                    This study evaluates the efficacy and safety of IRE (irreversible electroporation) ablation in the management of BPH (benign prostatic hyperplasia). Clinical data from 9 patients with prostate hyperplasia who underwent IRE treatment between September 2022 and August 2024 were retrospectively analyzed. Outcomes were assessed to determine the effectiveness and safety of IRE in ablating hyperplastic prostate tissue. IRE ablation was successfully performed in all patients. Postoperative assessments showed no significant reduction in prostate volume compared to preoperative measurements, This might be related to the mechanism of action of IRE. However, maximum urine flow rate significantly increased, and PVR (residual urine volume) significantly decreased. Additionally, the IPSS (International Prostate Symptom Score) showed a statistically significant improvement (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.05) compared to preoperative values. Sexual function remained largely unaffected. Adverse reactions were reported in 2 cases (22%). IRE has demonstrated better efficacy and an acceptable safety profile, accompanied by a low incidence of postoperative complications in the treatment of BPH. This technique provides a novel alternative for clinical management. However, due to the limited sample size in this study, further validation through long-term follow-up studies and expanded cohorts is necessary to confirm its sustained effectiveness.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000046166","type":"journal-article","created":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T14:01:51Z","timestamp":1764597711000},"page":"e46166","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Preliminary clinical outcomes of irreversible electroporation in the management of prostatic hyperplasia"],"prefix":"10.1097","volume":"104","author":[{"given":"Zhiyu","family":"Yu","sequence":"first","affiliation":[{"name":"Department of Urology, The First Hospital of China Medical University, Shenyang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quan","family":"Wen","sequence":"additional","affiliation":[{"name":"Department of Urology, Tongliao People\u2019s Hospital, TongLiao, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunpeng","family":"Guo","sequence":"additional","affiliation":[{"name":"Graduate School of Inner Mongolia Medical University, Hohhot, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Long","family":"Chen","sequence":"additional","affiliation":[{"name":"Graduate School of Inner Mongolia Medical University, Hohhot, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuyang","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Urology, Tongliao People\u2019s Hospital, TongLiao, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gai","family":"Hang","sequence":"additional","affiliation":[{"name":"Department of Urology, Tongliao People\u2019s Hospital, TongLiao, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1049-0686","authenticated-orcid":false,"given":"Bo","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Urology, Tongliao People\u2019s Hospital, TongLiao, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20260121","doi-asserted-by":"crossref","first-page":"170","DOI":"10.4103\/0970-1591.126900","article-title":"Epidemiology and etiology of benign prostatic hyperplasia and bladder outlet obstruction.","volume":"30","author":"Patel","year":"2014","journal-title":"Indian J Urol"},{"key":"R2-20260121","first-page":"1131","article-title":"Effects of Terazosin hydrochloride combined with finasteride tablets on serum TNF-\u03b1 and PSA levels in elderly patients with benign prostatic hyperplasia.","volume":"39","author":"Miao","year":"2019","journal-title":"Chin J Gerontol"},{"key":"R3-20260121","doi-asserted-by":"crossref","first-page":"100672","DOI":"10.1016\/j.lanepe.2023.100672","article-title":"Prstatic arteryembolisation versus medical treatment in patients with benignprstatic hyperplasia (PARTEM): a randomized, multicentre, open-label, phase 3, superiority trial.","volume":"31","author":"Sapoval","year":"2023","journal-title":"Lancet Reg Health Eur"},{"key":"R4-20260121","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s13014-017-0786-z","article-title":"An appraisal of analytical tools used in predicting clinical outcomes following radiation therapy treatment of men with prostate cancer: a systematic review.","volume":"12","author":"Raymond","year":"2017","journal-title":"Radiat Oncol"},{"key":"R5-20260121","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s10439-005-8981-8","article-title":"Tissue ablation with irreversible electroporation.","volume":"33","author":"Davalos","year":"2005","journal-title":"Ann Biomed Eng"},{"issue":"4 Suppl","key":"R6-20260121","first-page":"e964","article-title":"Irreversible electroporation (IRE) as a localized treatment for prostate cancer: a report on safety and outcomes.","volume":"193","author":"Murray","year":"2015","journal-title":"J Urol"},{"key":"R7-20260121","first-page":"320","article-title":"Pathological observation of liver during ablation of gallbladder side by irreversible electroporation in rabbits.","volume":"23","author":"Liang","year":"2014","journal-title":"J Interv Radiol"},{"key":"R8-20260121","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/pcan.2015.47","article-title":"Focal irreversible electroporationfor prostate cancer: functional outcomes and short-term oncological control.","volume":"19","author":"Ting","year":"2016","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"R9-20260121","first-page":"284","article-title":"Study on the correlation between prostate hyperplasia and renal function in elderly male patients.","volume":"37","author":"Wang","year":"2018","journal-title":"Chin J Geriatr"},{"key":"R10-20260121","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00270-020-02657-5","article-title":"Systematic review and meta-analysis comparing prostatic artery embolization to gold standard transurethral resection of the prostate for benign prostatic hyperplasia.","volume":"44","author":"Knight","year":"2021","journal-title":"Cardiovasc Intervent Radiol"},{"key":"R11-20260121","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.juro.2016.02.2986","article-title":"Pilot study to assess safety and clinical outcomes of irreversible electroporation for partial gland ablation in men with prostate cancer.","volume":"196","author":"Murray","year":"2016","journal-title":"J Urol"},{"key":"R12-20260121","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/bju.12227","article-title":"Bilateral focal ablation of prostate tissue using low-energy direct current (LEDC): a preclinical canine study.","volume":"112","author":"Kim","year":"2013","journal-title":"BJU Int"},{"key":"R13-20260121","doi-asserted-by":"crossref","first-page":"e18831","DOI":"10.1371\/journal.pone.0018831","article-title":"The effects of irreversible electroporation (IRE) on nerves.","volume":"6","author":"Li","year":"2011","journal-title":"PLoS One"},{"key":"R14-20260121","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1177\/153303460700600405","article-title":"Irreversible electroporation: implications for prostate ablation.","volume":"6","author":"Onik","year":"2007","journal-title":"Technol Cancer Res Treat"},{"key":"R16-20260121","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.bbrc.2013.05.039","article-title":"Changes of apoptosis in tumor tissues with time after irreversible electroporation.","volume":"435","author":"Kim","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"issue":"Suppl 4","key":"R17-20260121","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/bju.15946","article-title":"Median 5-year outcomes of primary focal irreversible electroporation for localised prostate cancer.","volume":"131","author":"Scheltema","year":"2023","journal-title":"BJU Int"},{"key":"R18-20260121","first-page":"674","article-title":"Single-center retrospective study of focal treatment of high frequency irreversible electroporation for prostate cancer.","volume":"39","author":"Yan","year":"2024","journal-title":"J Clin Urol"},{"key":"R19-20260121","first-page":"673","article-title":"Treatment of pancreatic cancer by irreversible electroporation.","volume":"32","author":"He","year":"2024","journal-title":"J Clin Surg"},{"key":"R20-20260121","first-page":"928","article-title":"Research progress of irreversible electroporation in the treatment of malignant tumor.","volume":"40","author":"Wu","year":"2024","journal-title":"Chin Med Imaging Technol"},{"key":"R21-20260121","first-page":"272","article-title":"Research progress of focal treatment of prostate cancer.","volume":"30","author":"Bai","year":"2024","journal-title":"Chin J Androl"},{"key":"R22-20260121","first-page":"498","article-title":"Research progress of irreversible electroporation for tumor ablation.","volume":"32","author":"Liu","year":"2023","journal-title":"J Interv Radiol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000046166","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T11:03:53Z","timestamp":1768993433000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000046166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,28]]},"references-count":21,"journal-issue":{"issue":"48","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000046166","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,28]]},"assertion":[{"value":"2025-07-01","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-20","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}